J. Goldman & CO LP Biom X Inc. Transaction History
J. Goldman & CO LP
- $2.89 Billion
- Q1 2024
A detailed history of J. Goldman & CO LP transactions in Biom X Inc. stock. As of the latest transaction made, J. Goldman & CO LP holds 150,000 shares of PHGE stock, worth $51,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150,000Holding current value
$51,000% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding PHGE
# of Institutions
11Shares Held
13.8MCall Options Held
0Put Options Held
0-
Deerfield Management Company, L.P. (Series C) New York, NY6.11MShares$2.08 Million0.06% of portfolio
-
Orbimed Advisors LLC San Diego, CA4.52MShares$1.54 Million0.05% of portfolio
-
Johnson & Johnson New Brunswick, NJ1.92MShares$653,8880.18% of portfolio
-
8 Vc Gp I, LLC Austin, TX1.09MShares$369,3040.62% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny80.6KShares$27,4040.0% of portfolio
About BiomX Inc.
- Ticker PHGE
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,982,300
- Market Cap $10.2M
- Description
- BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibr...